Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

BACKGROUND: KRAS was reported to affect some metabolic genes and promote metabolic reprogramming in solid tumors. However, there was no comprehensive analysis to explore KRAS-associated metabolic signature or risk model for pancreatic cancer (PC). METHODS: In the current study, multiple bioinformati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zuyi, Li, Zhenchong, Ma, Zuguang, Zhou, Zixuan, Zhuang, Hongkai, Liu, Chunsheng, Huang, Bowen, Zou, Yiping, Zheng, Zehao, Yang, LinLing, Gong, Yuanfeng, Huang, Shanzhou, Zhou, Qi, Zhang, Chuanzhao, Hou, Baohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516536/
https://www.ncbi.nlm.nih.gov/pubmed/34660806
http://dx.doi.org/10.1155/2021/9949272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516536/
https://www.ncbi.nlm.nih.gov/pubmed/34660806
http://dx.doi.org/10.1155/2021/9949272

Ejemplares similares